optimization studies as a guide,19,22 but the starting material
failed to convert. This may be the result of the ability of
the thiophene to deactivate the palladium catalyst via
coordination of its sulfur atom. However, using Mori’s
conditions, the C–H bond of the thiophene 18 was selectively
arylated using both palladium and silver catalysts and iodo-
benzene as the arene source.25 The SEM protecting group of
compound 19 was cleaved by treatment with tetrabutyl-
ammonium fluoride (TBAF) in DMF to afford 20 and
subsequent N-alkylation was carried out with N-(4-bromobutyl)-
phthalimide in the presence of potassium tert-butoxide to
afford the N-alkylindole 21. Finally, the BoNTA inhibitor 1
was synthesized following the procedure of Pang by treating
21 with excess hydroxylamine, which simultaneously converts
the methyl ester and phthalimide to hydroxamic acid and
amine, respectively (Scheme 3).4
Notes and references
1 D. O. P. Fleming and D. L. Hunt, Biological Safety: Principles
and Practices, ASM Press, 4th edn, 2006.
2 T. Cote, A. Mohan, J. Polder, M. Walton and M. Braun, J. Am.
Acad. Dermatol., 2005, 53, 407–415.
3 K. R. Kessler and R. Benecke, Neurotoxicology, 1997, 18, 761–770.
4 J. Tang, J. G. Park, C. B. Millard, J. J. Schmidt and Y. Pang, PLoS
One, 2007, 2, e761.
5 Y. Pang, A. Vummenthala, R. K. Mishra, J. G. Park, S. Wang,
J. Davis, C. B. Millard and J. J. Schmidt, PLoS One, 2009, 4, e7730.
6 J. G. Park, P. C. Sill, E. F. Makiyi, A. T. Garcia-Sosa,
C. B. Millard, J. J. Schmidt and Y. Pang, Bioorg. Med. Chem.,
2006, 14, 395–408.
7 Y. Pang, J. Davis, S. Wang, J. G. Park, M. P. Nambiar,
J. J. Schmidt and C. B. Millard, PLoS One, 2010, 5, e10129.
8 T. Itahara, J. Chem. Soc., Chem. Commun., 1981, 254.
9 T. Itahara, K. Kawasaki and F. Ouseto, Bull. Chem. Soc. Jpn.,
1984, 57, 3488–3493.
10 T. Itahara, J. Org. Chem., 1985, 50, 5272–5275.
11 G. P. McGlacken and L. M. Bateman, Chem. Soc. Rev., 2009, 38,
2447–2464.
12 X. Chen, K. Engle, D. Wang and J. Yu, Angew. Chem., Int. Ed.,
2009, 48, 5094–5115.
13 L. Joucla and L. Djakovitch, Adv. Synth. Catal., 2009, 351, 673–714.
14 C. Li, Acc. Chem. Res., 2009, 42, 335–344.
15 B. Li, S. Yang and Z. Shi, Synlett, 2008, 2008, 949–957.
16 D. Alberico, M. E. Scott and M. Lautens, Chem. Rev., 2007, 107,
174–238.
17 B. M. Trost, Angew. Chem., Int. Ed. Engl., 1995, 34, 259–281.
18 R. A. Sheldon, Pure Appl. Chem., 2000, 72, 1233–1246.
19 S. Potavathri, K. C. Pereira, S. I. Gorelsky, A. Pike, A. P. LeBris
and B. DeBoef, J. Am. Chem. Soc., 2010, 132, 14676–14681.
20 S. Potavathri, A. S. Dumas, T. A. Dwight, G. R. Naumiec,
J. M. Hammann and B. DeBoef, Tetrahedron Lett., 2008, 49,
4050–4053.
In conclusion, we have developed a novel synthetic route for
the synthesis of an inhibitor of botulinum neurotoxin serotype
A (BoNTA). The 4.6% overall yield is nearly identical to that
which was reported by Pang, but the step economy of the
overall synthesis has been increased due to the incorporation
of reactions which do not rely on prefunctionalized starting
materials; rather the biaryl C–C bonds were directly formed
from the C–H bonds of simple arenes and heteroarenes. It should
also be noted that the C–H functionalizing reactions are two of the
highest yielding steps in this synthesis. While our initial attempts to
form biaryl C–C bonds with thiophene-type substrates such as 18
were not successful, efforts in our laboratory are currently focused
on expanding our oxidative coupling methods to encompass these
and other classes of heteroarenes for application to the synthesis of
more high-value targets.
21 D. R. Stuart, E. Villemure and K. Fagnou, J. Am. Chem. Soc.,
2007, 129, 12072–12073.
22 T. A. Dwight, N. R. Rue, D. Charyk, R. Josselyn and B. DeBoef,
Org. Lett., 2007, 9, 3137–3139.
23 D. R. Stuart and K. Fagnou, Science, 2007, 316, 1172–1175.
This work was supported by the National Science Founda-
tion (CAREER 0847222) and a Pilot/Feasibility Grant
from the Rhode Island INBRE Program (NIH-NCRR
P20RR016457).
24 Toure, B. S. Lane and D. Sames, Org. Lett., 2006, 8, 1979–1982.
´
25 K. Kobayashi, A. Sugie, M. Takahashi, K. Masui and A. Mori,
Org. Lett., 2005, 7, 5083–5085.
c
This journal is The Royal Society of Chemistry 2011
Chem. Commun., 2011, 47, 4679–4681 4681